Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 24:
Amicus Therapeutics, Inc. FOLD: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
Amicus Therapeutics' shares gained 10.2% over the last three months compared with the S&P 500’s advanced of 6.8%. The company possesses a Momentum Score of A.
Clipper Realty Inc. CLPR: This real estate company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.6% over the last 60 days.
Clipper Realty's shares gained 68.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of B.
Harrow, Inc. HROW: This eyecare pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 164.3% over the last 60 days.
Harrow's shares gained 127.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amicus Therapeutics, Inc. (FOLD): Free Stock Analysis Report
Clipper Realty Inc. (CLPR): Free Stock Analysis Report
Harrow, Inc. (HROW): Free Stock Analysis Report